Journal of Palliative Care & Medicine
Open Access

Palliative radiotherapy; Cancer symptom; Interdisciplinary palliative care; Quality of life; Advanced cancer

Introduction

Palliative radiotherapy (PRT) holds a crucial role in alleviating cancer-related symptoms, significantly improving the quality of life for individuals with advanced cancer. Despite its recognized efficacy, the widespread implementation of PRT faces obstacles that may impede patient support during treatment. Proposed strategies include specialized training for supportive and palliative care specialists in PRT and integrating palliative care education into the training of radiation oncologists [1]. One significant barrier to the effective use of PRT in palliative care is the lack of specialized training for supportive and palliative care specialists in radiotherapy techniques. Although palliative care specialists excel in managing symptoms through medications and psychosocial support, they may lack expertise in PRT [2]. Addressing this gap involves developing specialized training programs that educate palliative care teams on PRT principles and practices. These programs should concentrate on educating palliative care specialists about PRT indications, potential benefits, and the management of common radiation-related side effects [3]. By enhancing the knowledge and skills of these professionals, patients can benefit from a more comprehensive and coordinated approach to symptom management, integrating both pharmaceutical and radiation-based interventions. Conversely, radiation oncologists, primarily trained for curative treatments, may need additional education in palliative care principles. While experts in radiotherapy techniques, radiation oncologists may not always possess the expertise for effective complex symptom management and psychosocial support [4-6]. Bridging this gap involves incorporating palliative care training into the curriculum of radiation oncologists during their residency and continuous medical education. This ensures that radiation oncologists can not only plan and deliver PRT but also assess and manage symptoms and collaborate effectively in multidisciplinary palliative care teams. Introducing dedicated pathways and organizational models for PRT is crucial for enhancing its effectiveness and integrating it seamlessly into palliative care for advanced cancer patients [7].These pathways and models provide structured frameworks guiding healthcare providers in the strategic and coordinated use of PRT in the palliative setting. Dedicated pathways offer clear and standardized guidelines for healthcare providers on the appropriate utilization of PRT. These guidelines help identify patients who would benefit the most from PRT, considering factors such as cancer type, stage, specific symptoms, and overall patient condition. Well-defined eligibility criteria ensure that PRT is administered when likely to provide significant symptom relief, preventing unnecessary radiation therapy in cases where benefits may be limited [8]. These pathways enable informed decision-making by providing insights into the potential benefits and risks associated with PRT. Healthcare providers can discuss treatment options more comprehensively with patients and their families, ensuring active involvement in care decisions aligned with preferences and goals [9]. Organizational models integrating PRT with other supportive therapies optimize patient care. This holistic approach recognizes that cancer care extends beyond radiation treatment alone. By combining PRT with other supportive care forms, patients receive a comprehensive and well-rounded treatment plan addressing physical, psychosocial, and emotional needs [10 ]. Organizational models improve communication and coordination among healthcare providers. Seamless integration with other palliative care services enables effective collaboration, ensuring timely and appropriate interventions. This proactive approach prevents care delays, minimizing the burden on patients and their families [11-15]. Palliative radiotherapy (PRT) serves as a crucial tool in alleviating cancer-related symptoms and enhancing the overall quality of life for patients with advanced cancer. However, the integration of PRT into palliative care encounters various challenges that impede its widespread adoption and may affect patient support during treatment. This article explores strategies to overcome these barriers and optimize the effectiveness of PRT through a multidisciplinary approach. The first key strategy involves prioritizing specialized training for supportive and palliative care specialists in PRT. While these professionals are adept at managing symptoms through medications and psychosocial support, their expertise in radiotherapy techniques may be limited. Specialized training programs can bridge this gap, ensuring that palliative care teams are well-versed in the principles and practices of PRT. This approach fosters a comprehensive and coordinated approach to symptom management, integrating both pharmaceutical and radiation-based interventions. Similarly, incorporating palliative care education into the training of radiation oncologists is essential. While radiation oncologists excel in radiotherapy techniques for curative treatments, additional education in palliative care principles ensures they can effectively address complex symptom management and provide psychosocial support. This comprehensive training equips radiation oncologists not only to plan and deliver PRT but also to assess and manage symptoms and collaborate efficiently in multidisciplinary palliative care teams. Another critical strategy involves the introduction of dedicated pathways and organizational models for PRT. These structured frameworks guide healthcare providers in the strategic and coordinated use of PRT in the palliative setting. Clear guidelines for appropriate use ensure that PRT is administered when most likely to provide significant symptom relief, preventing unnecessary radiation therapy in cases where its benefits may be limited. Furthermore, these pathways enable informed decision-making by providing insights into the potential benefits and risks associated with PRT, facilitating comprehensive discussions between healthcare providers, patients, and their families. The integration of PRT with other supportive therapies, such as hospice and palliative care services, is instrumental in optimizing patient care. This holistic approach recognizes that cancer care extends beyond radiation treatment alone. By combining PRT with other forms of supportive care, patients receive a comprehensive and well-rounded treatment plan addressing not only their physical symptoms but also their psychosocial and emotional needs. This synergy between treatment modalities can lead to more effective symptom management and an overall improved quality of life for patients with advanced cancer. In conclusion, a collaborative and multidisciplinary approach is pivotal to overcoming barriers in the widespread implementation of PRT in palliative care. By prioritizing specialized training, implementing dedicated pathways, and integrating PRT with supportive therapies, healthcare providers can enhance the effectiveness of PRT, improve patient outcomes, and ultimately contribute to a higher quality of life for individuals facing the challenges of advanced cancer.

Conclusion

In summary, palliative radiotherapy stands as a valuable tool for alleviating cancer-related symptoms and enhancing the quality of life for patients with advanced cancer. Nevertheless, the integration of PRT into palliative care encounters various barriers that impede its widespread adoption and impact patient support during treatment. To surmount these challenges and elevate the effectiveness of PRT, it is essential to prioritize specialized training for supportive and palliative care specialists in PRT, along with incorporating palliative care education into the training of radiation oncologists. Additionally, the introduction of dedicated pathways and organizational models for PRT can facilitate its seamless integration into palliative care. While evidence on innovative organizational models and training experiences is still limited, existing studies underscore the advantages of integrating PRT with supportive therapies and fostering collaboration in multidisciplinary palliative care teams. These frameworks offer clear guidelines for PRT use, promote informed decision-making, and facilitate integration with other supportive therapies. This approach enhances communication and coordination among healthcare providers, ultimately benefiting the well-being of patients and their families navigating the challenges of advanced cancer. By implementing these strategic approaches, healthcare providers can collectively overcome barriers, ensuring that PRT is readily available and effectively utilized in the care of patients with advanced cancer. This concerted effort aims to improve the quality of life for patients during these challenging times, emphasizing a comprehensive and collaborative approach to palliative care.

Acknowledgement

Not applicable.

Conflict of Interest

Author declares no conflict of interest.

1. Todd A, Al-Khafaji J, Akhter N, Kasim A, Quibell R, et al. (2018) Missed opportunities: Unnecessary medicine use in patients with lung cancer at the end of life–An international cohort study. Br J Clin Pharmacol 84:2802-2810.

Indexed at, Google Scholar, Crossref

2. Curtin D, Gallagher P, O’Mahony D (2021) Deprescribing in older people approaching end-of-life: Development and validation of STOPPFrail version 2. Age Ageing 50:465-471.

Indexed at, Google Scholar, Crossref

3. Vallianatos S, Huizinga CS (2021) Development of the Dutch Structure for Integrated Children’s Palliative Care. Children 8:741.

Indexed at, Google Scholar, Crossref

4. Curtin D, Gallagher P, O’Mahony D (2021) Deprescribing in older people approaching end-of-life: Development and validation of STOPPFrail version 2. Age Ageing 50:465-471.

Indexed at, Google Scholar, Crossref

5. Lindsay J, Dooley M, Martin J, Fay M, Kearney A, et al. (2015) The development and evaluation of an oncological palliative care deprescribing guideline: The ‘OncPal deprescribing guideline’. Support Care Cancer Off J Multinatl Assoc 23:71-78.

Indexed at, Google Scholar, Crossref

6. Bergstrom H, Branvall E, Helde-Frankling M, Bjorkhem-Bergman L (2018) Differences in discontinuation of statin treatment in women and men with advanced cancer disease. Biol Sex Differ 9:47.

Indexed at, Google Scholar, Crossref

7. Kutner JS, Blatchford PJ, Taylor DH Jr, Ritchie CS, Bull JH, et al. (2015) Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness: A randomized clinical trial. JAMA Intern Med 175:691-700.

Indexed at, Google Scholar, Crossref

8. Marrs JC, Kostoff MD (2016) Discontinuation of Statins: What Are the Risks? Curr Atheroscler Rep 18:41.

Indexed at, Google Scholar, Crossref

9. Zhukovsky DS, Rozmus CL (2021) Symptom and Illness Experience for English and Spanish-Speaking Children with Advanced Cancer: Child and Parent Perspective. Children 8:657.

Indexed at, Google Scholar, Crossref

10. Mekelenkamp H, Schröder T (2021) Specialized Pediatric Palliative Care Services in Pediatric Hematopoietic Stem Cell Transplant Centers. Children 8:615.

Indexed at, Google Scholar, Crossref

11. Baumann F, Hebert, S (2021) Clinical Characteristics of the End-of-Life Phase in Children with Life-Limiting Diseases: Retrospective Study from a Single Center for Pediatric Palliative Care. Children 8:523.

Indexed at, Google Scholar, Crossref

12. Pisani L, Hill NS, Pacilli AMG, Polastri M, Nava S (2018) Management of Dyspnea in the Terminally Ill. Chest 154:925-934.

Indexed at, Google Scholar, Crossref

13. Turner JP, Shakib S, Singhal N, Hogan-Doran J, Prowse R, et al. (2014) Statin use and pain in older people with cancer: A cross-sectional study. J Am Geriatr Soc 62:1900-1905.

Indexed at, Google Scholar, Crossref

14. Ravindrarajah R, Hazra NC, Hamada S, Charlton J, Jackson SHD, et al. (2017) Systolic Blood Pressure Trajectory, Frailty, and All-Cause Mortality >80 Years of Age: Cohort Study Using Electronic Health Records. Circulation 135:2357-2368.

Indexed at, Google Scholar, Crossref

15. Meyer-Junco L (2021) Time to Deprescribe: A Time-Centric Model for Deprescribing at End of Life. J Palliat Med 24:273-284.

Indexed at, Google Scholar, Crossref